diabetes - Publications - Faculty & Research

01 Sep 2008
News

Mara Aspinall

pharmaceutical companies focused their R&D on treatments for common illnesses — such as diabetes and high cholesterol — an approach that resulted in the development of blockbuster drugs. We now recognize that diseases are far more complex... View Details

Keywords: Deborah Blagg; Ambulatory Health Care Services; Health, Social Assistance

05 Jun 2006
Research & Ideas

Using Competition to Reform Healthcare

(through age twelve), adolescent (ages thirteen to twenty-two), and adult (over the age of twenty-two). Its expertise with adult patients has led to the development of a specialized reproductive practice for cystic fibrosis patients, with excellent results.5 The center... View Details

Keywords: by Michael E. Porter; Health

01 Dec 2001
News

Reaching Out

particularly interesting to Mukhtar, based on his experience as a physician in Nigeria, where medical treatment is essentially unavailable or unaffordable for much of the population. "One cohort in Singapore that is highly susceptible to hypertension and View Details

Keywords: Garry Emmons and Julia Hanna; Health, Social Assistance

01 Mar 2009
News

Model Patient

would provide the specialists and the full range of necessary care for patients suffering from chronic diseases or disabilities such as diabetes or bad backs. Rather than leaving it to the patient to search for a specialist in one area,... View Details

Keywords: Garry Emmons; Health, Social Assistance

20 Dec 2022
News

Singing to the Corn

Nation in health care, with a focus on preventing diabetes in indigenous populations. "I quickly realized that business alone was not enough to reverse the dysfunction of some tribal economies," says Keen. Earlier, he'd experienced the... View Details

15 Jan 2013
First Look

First Look: January 15

KnoopHarvard Business School Case 813-091 Amylin Pharmaceuticals brought two first-in-class diabetes drugs to market, Byetta and Symlin, in 2005, which were sold in over 80 countries with $650.7 million in sales by 2011. However, the... View Details

Keywords: Sean Silverthorne

07 Apr 2009
First Look

First Look: April 7, 2009

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=109057 Amylin Pharmaceuticals: Diabetes and Beyond Harvard Business School Case 809-011 Ginger Graham, CEO of Amylin Pharmaceuticals, joined the company with the expectation... View Details

Keywords: Martha Lagace

01 Dec 2016
News

Alumni Books of 2016

unprecedented rates. Diabetes rates have boomed. Online data thefts have surged. Urbanization and waste have soared. What is happening? Is it globalization? Or is something much deeper taking place, something that the world had never... View Details

Publications